Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments
The pharmacological treatment of cognitive impairments associated with schizophrenia is still a major unmet clinical need. Indeed, treatments with available antipsychotics generate highly variable cognitive responses among patients with schizophrenia. This has led to the general assumption that anti...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2020-11-01
|
| Serier: | Pharmaceuticals |
| Fag: | |
| Online adgang: | https://www.mdpi.com/1424-8247/13/11/365 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
